SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-021921
Filing Date
2023-08-03
Accepted
2023-08-03 16:03:02
Documents
14
Period of Report
2023-08-01
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230803_8k.htm   iXBRL 8-K 24783
2 EXHIBIT 4.1 ex_554327.htm EX-4.1 51847
  Complete submission text file 0001437749-23-021921.txt   236664

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230801.xsd EX-101.SCH 3850
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230801_def.xml EX-101.DEF 13382
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230801_lab.xml EX-101.LAB 17549
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230801_pre.xml EX-101.PRE 13359
8 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230803_8k_htm.xml XML 4278
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 231139778
SIC: 2836 Biological Products, (No Diagnostic Substances)